Cargando…

The associations between central serous chorioretinopathy and muscle relaxants: A case–control study

PURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Manish, Garg, Sunir J., Khan, Mohammad, Chaudhary, Varun, Zeraatkar, Dena, Kurian, Dhanya, Lal, Sarath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843563/
https://www.ncbi.nlm.nih.gov/pubmed/36660119
http://dx.doi.org/10.4103/2211-5056.361975
_version_ 1784870437660917760
author Jain, Manish
Garg, Sunir J.
Khan, Mohammad
Chaudhary, Varun
Zeraatkar, Dena
Kurian, Dhanya
Lal, Sarath
author_facet Jain, Manish
Garg, Sunir J.
Khan, Mohammad
Chaudhary, Varun
Zeraatkar, Dena
Kurian, Dhanya
Lal, Sarath
author_sort Jain, Manish
collection PubMed
description PURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS: Retrospective case-control study at a tertiary hospital in the United Arab Emirates, where we reviewed the medical records of 273 patients with CSC examined between 2010 and 2019 for use of muscle-relaxants including tolperisone/eperisone, carisoprodol and gabapentin/pregabalin within a year of onset/recurrence of the disease. Intake of drugs with known association with CSC (including corticosteroids/sympathomimetics) was also recorded. Two hundred eighty-six subjects with adverse events seen at the same institute during the same study period served as controls. Odds ratios, Chi-Square tests and multivariate logistic regression were carried out to determine any associations with the muscle-relaxants and other pharmacological confounders - corticosteroids/sympathomimetics. RESULTS: Muscle relaxants may increase the risk of CSC as evident on multivariate regression analysis (OR: 2.55; confidence interval [CI]: 1.208-5.413); the significance was retained on removing the 6 subjects who had corticosteroids/sympathomimetics (OR: 2.30; CI: 1.073–4.939). Univariate analysis yielded an OR of 2.52 for muscle relaxants (CI: 1.2149–5.2276), 2.96 for eperisone/tolperisone (CI: 1.3531–6.5038), and 6.26 for eperisone as an individual agent (CI: 1.8146–21.6252). CONCLUSION: We found muscle relaxants to be associated factors of CSC regardless of inclusion of corticosteroids/sympathomimetics (P < 0.05). Among individual classes of muscle relaxants in this study, only eperisone/tolperisone posed a significant risk (P < 0.05). The vascular smooth muscle relaxation could be the possible mechanism that affects the choroidal blood flow and indirectly predisposes to CSC.
format Online
Article
Text
id pubmed-9843563
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98435632023-01-18 The associations between central serous chorioretinopathy and muscle relaxants: A case–control study Jain, Manish Garg, Sunir J. Khan, Mohammad Chaudhary, Varun Zeraatkar, Dena Kurian, Dhanya Lal, Sarath Taiwan J Ophthalmol Original Article PURPOSE: To evaluate the role of muscle-relaxants as risk factors for the development of central serous chorioretinopathy (CSC) - the second most common retinopathy in our settings; despite multiple risk factors seen in our patients, 21% were initially labelled as idiopathic. MATERIALS AND METHODS: Retrospective case-control study at a tertiary hospital in the United Arab Emirates, where we reviewed the medical records of 273 patients with CSC examined between 2010 and 2019 for use of muscle-relaxants including tolperisone/eperisone, carisoprodol and gabapentin/pregabalin within a year of onset/recurrence of the disease. Intake of drugs with known association with CSC (including corticosteroids/sympathomimetics) was also recorded. Two hundred eighty-six subjects with adverse events seen at the same institute during the same study period served as controls. Odds ratios, Chi-Square tests and multivariate logistic regression were carried out to determine any associations with the muscle-relaxants and other pharmacological confounders - corticosteroids/sympathomimetics. RESULTS: Muscle relaxants may increase the risk of CSC as evident on multivariate regression analysis (OR: 2.55; confidence interval [CI]: 1.208-5.413); the significance was retained on removing the 6 subjects who had corticosteroids/sympathomimetics (OR: 2.30; CI: 1.073–4.939). Univariate analysis yielded an OR of 2.52 for muscle relaxants (CI: 1.2149–5.2276), 2.96 for eperisone/tolperisone (CI: 1.3531–6.5038), and 6.26 for eperisone as an individual agent (CI: 1.8146–21.6252). CONCLUSION: We found muscle relaxants to be associated factors of CSC regardless of inclusion of corticosteroids/sympathomimetics (P < 0.05). Among individual classes of muscle relaxants in this study, only eperisone/tolperisone posed a significant risk (P < 0.05). The vascular smooth muscle relaxation could be the possible mechanism that affects the choroidal blood flow and indirectly predisposes to CSC. Wolters Kluwer - Medknow 2022-11-28 /pmc/articles/PMC9843563/ /pubmed/36660119 http://dx.doi.org/10.4103/2211-5056.361975 Text en Copyright: © 2022 Taiwan J Ophthalmol https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Jain, Manish
Garg, Sunir J.
Khan, Mohammad
Chaudhary, Varun
Zeraatkar, Dena
Kurian, Dhanya
Lal, Sarath
The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_full The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_fullStr The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_full_unstemmed The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_short The associations between central serous chorioretinopathy and muscle relaxants: A case–control study
title_sort associations between central serous chorioretinopathy and muscle relaxants: a case–control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843563/
https://www.ncbi.nlm.nih.gov/pubmed/36660119
http://dx.doi.org/10.4103/2211-5056.361975
work_keys_str_mv AT jainmanish theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT gargsunirj theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT khanmohammad theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT chaudharyvarun theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT zeraatkardena theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT kuriandhanya theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT lalsarath theassociationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT jainmanish associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT gargsunirj associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT khanmohammad associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT chaudharyvarun associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT zeraatkardena associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT kuriandhanya associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy
AT lalsarath associationsbetweencentralserouschorioretinopathyandmusclerelaxantsacasecontrolstudy